Home

Sick person Lodging Starting point filsuvez gel Continuous Infant Hardness

Filsuvez® gel approved for use in the EU | DEBRA UK
Filsuvez® gel approved for use in the EU | DEBRA UK

A third FDA-approved botanical drug is on the horizon.
A third FDA-approved botanical drug is on the horizon.

Birkenrindenextrakt zur Wundheilung zugelassen
Birkenrindenextrakt zur Wundheilung zugelassen

Filsuvez Gel, 30 x 23,4 g online kaufen | DocMorris
Filsuvez Gel, 30 x 23,4 g online kaufen | DocMorris

FILSUVEZ (extracto de corteza de abedul) - Perset Farma
FILSUVEZ (extracto de corteza de abedul) - Perset Farma

Filsuvez Significantly Reduces DEB Wounds After 15 Months in EASE Trial |  Patients on Filsuvez Report Less Pain During Wound Dressings in Trial |  Epidermolysis Bullosa News
Filsuvez Significantly Reduces DEB Wounds After 15 Months in EASE Trial | Patients on Filsuvez Report Less Pain During Wound Dressings in Trial | Epidermolysis Bullosa News

Amryt Due For Oral Explanation At EMA For Epidermolysis Bullosa Gel Filsuvez  :: Pink Sheet
Amryt Due For Oral Explanation At EMA For Epidermolysis Bullosa Gel Filsuvez :: Pink Sheet

Filsuvez recommended for use in NHS to treat EB - Cure EB
Filsuvez recommended for use in NHS to treat EB - Cure EB

Filsuvez, Topical Gel for Epidermolysis Bullosa, Under FDA Priority Review
Filsuvez, Topical Gel for Epidermolysis Bullosa, Under FDA Priority Review

CHMP Supports Filsuvez Gel Approval in Europe for DEB, JEB
CHMP Supports Filsuvez Gel Approval in Europe for DEB, JEB

FILSUVEZ - Amryt Research Ltd Trademark Registration
FILSUVEZ - Amryt Research Ltd Trademark Registration

FILSUVEZ - Amryt Research Ltd Trademark Registration
FILSUVEZ - Amryt Research Ltd Trademark Registration

FDA Decision on Filsuvez Gel for EB Wounds Now Due in February
FDA Decision on Filsuvez Gel for EB Wounds Now Due in February

Filsuvez, Topical Gel for Epidermolysis Bullosa, Under FDA Priority Review
Filsuvez, Topical Gel for Epidermolysis Bullosa, Under FDA Priority Review

FDA Rejects Filsuvez Gel for Treating EB Skin Wounds, Seeks More Data
FDA Rejects Filsuvez Gel for Treating EB Skin Wounds, Seeks More Data

Moment Of Truth For Eight New Drugs In EU :: Pink Sheet
Moment Of Truth For Eight New Drugs In EU :: Pink Sheet

AMRYT ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TRIAL OF FILSUVEZ® IN  EPIDERMOLYSIS BULLOSA
AMRYT ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TRIAL OF FILSUVEZ® IN EPIDERMOLYSIS BULLOSA

Gene Therapy Gel Vyjuvek Granted FDA Priority Review for DEB | FDA to  Decide by Feb 17 on Application for Gene Therapy Gel Vyjuvek |  Epidermolysis Bullosa News
Gene Therapy Gel Vyjuvek Granted FDA Priority Review for DEB | FDA to Decide by Feb 17 on Application for Gene Therapy Gel Vyjuvek | Epidermolysis Bullosa News

Filsuvez Significantly Reduces DEB Wounds After 15 Months in EASE Trial |  Patients on Filsuvez Report Less Pain During Wound Dressings in Trial |  Epidermolysis Bullosa News
Filsuvez Significantly Reduces DEB Wounds After 15 Months in EASE Trial | Patients on Filsuvez Report Less Pain During Wound Dressings in Trial | Epidermolysis Bullosa News

Filsuvez Significantly Reduces DEB Wounds After 15 Months in EASE Trial |  Patients on Filsuvez Report Less Pain During Wound Dressings in Trial |  Epidermolysis Bullosa News
Filsuvez Significantly Reduces DEB Wounds After 15 Months in EASE Trial | Patients on Filsuvez Report Less Pain During Wound Dressings in Trial | Epidermolysis Bullosa News

FDA approves gene therapy gel Vyjuvek for DEB patients 6 months and older |  Vyjuvek becomes 1st, only approved therapy for DEB patients in US |  Epidermolysis Bullosa News
FDA approves gene therapy gel Vyjuvek for DEB patients 6 months and older | Vyjuvek becomes 1st, only approved therapy for DEB patients in US | Epidermolysis Bullosa News

Topical Treatment for EB Recommended for Approval in the EU
Topical Treatment for EB Recommended for Approval in the EU

Positive EB Trial Data Puts Filsuvez on Track for Regulatory Submissions
Positive EB Trial Data Puts Filsuvez on Track for Regulatory Submissions

Mit Birkenrinden-Extrakt gegen Epidermolysis bullosa
Mit Birkenrinden-Extrakt gegen Epidermolysis bullosa

Topical Morphine Gel Can Help Ease Pain of EB Wounds: Report | Gel Used to  Treat 3 Patients in UK With Good Results | Epidermolysis Bullosa News
Topical Morphine Gel Can Help Ease Pain of EB Wounds: Report | Gel Used to Treat 3 Patients in UK With Good Results | Epidermolysis Bullosa News

EMA Decision on Filsuvez Gel for EB Wounds Delayed by 2 Months
EMA Decision on Filsuvez Gel for EB Wounds Delayed by 2 Months

Filsuvez® Approval by EMA June 2022 - EB-Research
Filsuvez® Approval by EMA June 2022 - EB-Research

Debra Ireland - The Butterfly Skin Charity - The first medication  specifically developed to treat EB has successfully completed a Phase 3  clinical trial. Filsuvez is a topical therapeutic gel developed by
Debra Ireland - The Butterfly Skin Charity - The first medication specifically developed to treat EB has successfully completed a Phase 3 clinical trial. Filsuvez is a topical therapeutic gel developed by

Amryt Advances Applications for Filsuvez in Dystrophic Epidermolysis Bullosa
Amryt Advances Applications for Filsuvez in Dystrophic Epidermolysis Bullosa

Positive opinion for Amryt's Filsuvez - Cure EB
Positive opinion for Amryt's Filsuvez - Cure EB

Filsuvez® gel approved for use in Great Britain | DEBRA UK
Filsuvez® gel approved for use in Great Britain | DEBRA UK